Serial Number | 99091723 |
Word Mark | NORD CLAIM YOUR CARE |
Filing Date | Wednesday, March 19, 2025 |
Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
Status Date | Tuesday, September 16, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, October 7, 2025 |
Pseudo Mark | NATIONAL ORGANIZATION FOR RARE DISORDERS CLAIM YOUR CARE |
Goods and Services | Providing educational insurance information about health insurance coverage, insurance issues, and the navigation of each among Patient Advocacy Organizations, patients, caregivers, clinical staff, health plans, and employer groups in, and operating in, the rare disease community |
International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, March 19, 2025 |
Primary Code | 036 |
First Use Anywhere Date | Monday, March 10, 2025 |
First Use In Commerce Date | Monday, March 10, 2025 |
Party Name | National Organization for Rare Disorders |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Quincy, MA 02169 |
Event Date | Event Description |
Wednesday, March 19, 2025 | NEW APPLICATION ENTERED |
Thursday, July 10, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, August 19, 2025 | ASSIGNED TO EXAMINER |
Wednesday, August 20, 2025 | NON-FINAL ACTION E-MAILED |
Wednesday, August 20, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, September 8, 2025 | EXAMINER'S AMENDMENT ENTERED |
Monday, September 8, 2025 | EXAMINERS AMENDMENT -WRITTEN |
Monday, September 8, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Monday, September 8, 2025 | EXAMINERS AMENDMENT E-MAILED |
Monday, September 8, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, March 19, 2025 | APPLICATION FILING RECEIPT MAILED |
Wednesday, August 20, 2025 | NON-FINAL ACTION WRITTEN |